52 results
Page 2 of 3
6-K
EX-99.1
crf3 bv9u543wax2vd
30 Sep 20
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
6:00am
6-K
EX-99.1
874h21tzk6gcvzb r9r
13 Aug 20
Current report (foreign)
9:42am
6-K
EX-99.2
if3awf
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
14cps
24 Jul 20
Current report (foreign)
9:45am
6-K
EX-99.2
ghlpqnetikgbjatc8g
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.1
y3ladug3
16 Apr 20
Galapagos and Ryvu announce research collaboration
6:05am
6-K
EX-99.1
l2qux hhn467tpa44
15 Jan 20
Current report (foreign)
6:06am
6-K
EX-99.2
rmzsi7s4
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.1
f4nnw9o8eumwejl 25g
25 Sep 19
Current report (foreign)
10:50am
6-K
EX-99.2
bde xycpcjj8u2
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99
jro1ds w7cy5qlw
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99
3p9h6z80tj3doq
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.1
sosxbng
15 Jul 19
Gilead and Galapagos Enter into Transformative Research and Development Collaboration
11:59am
6-K
EX-99.1
swl42a08gkvo88slh 3s
11 Jun 19
Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
6:05am
6-K
EX-99.2
5kx2pd 7p7pdx9rrp1
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm
F-3ASR
kppkh5ifl1 xfo
29 Mar 19
Automatic shelf registration (foreign)
5:26pm
6-K
EX-99.1
t3i3es8949n doi5b
28 Nov 18
Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis
6:00am
6-K
EX-99.2
hlb362r wic
26 Oct 18
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
4:19pm